Microfracture Technique Combined with Autologous Platelet-Rich Plasma for Treatment of Osteochondral Injury of Talus
Objective:To investigate the clinical efficacy of microfracture combined with autologous platelet-rich plasma(PRP)on osteochondral injury of talus of Hepple stage Ⅴ.Methods:60 patients with stage Ⅴ talus osteochondral injury of Hepple were randomized.The control group(30 cases)was treated with microfracture technology,and the observation group(30 cases)was treated with microfracture technology combined with PRP injection.The clinical efficacy of the two groups was compared.Results:At 12 months after surgery,the visual analogue scale(VAS)scores of ankle pain in both groups were significantly lower than that before surgery,and the observation group was lower than the control group(P＜0.05).The American Foot and Ankle Association(AOFAS)ankle and hindfoot function scores,ankle range of motion and Short Form of Health Status Survey(SF-36)scores were higher than those before surgery,and the observation group were higher than the control group(P＜0.05).There was no significant difference in the incidence of complications between observation group and control group(P＞0.05).Conclusion:For Hepple stage Ⅴ patients with osteochondral injury of talus,the application of microfracture technology combined with PRP has a significant effect,which can effectively reduce the symptoms of ankle pain,promote the recovery of ankle function,improve the quality of life,and has good safety.
microfracture techniqueautologous platelet-rich plasmaosteochondral injury of talusankle joint function
NETL
NSTL
万方数据
